Immuneering (IMRX) Shares Issued: 2021-2024
Historic Shares Issued for Immuneering (IMRX) over the last 2 years, with Dec 2024 value amounting to $3.5 million.
- Immuneering's Shares Issued rose 44157.08% to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$23.6 million, marking a year-over-year decrease of 5395.22%. This contributed to the annual value of $4.2 million for FY2024, which is 844.16% up from last year.
- Per Immuneering's latest filing, its Shares Issued stood at $3.5 million for Q4 2024, which was up 373.41% from $732,458 recorded in Q1 2024.
- Immuneering's Shares Issued's 5-year high stood at $119.4 million during Q3 2021, with a 5-year trough of -$27.8 million in Q3 2023.
- Its 3-year average for Shares Issued is $494,522, with a median of $117,604 in 2022.
- Over the last 5 years, Immuneering's Shares Issued had its largest YoY gain of 100,535.60% in 2023, and its largest YoY loss of 74,360.42% in 2023.
- Quarterly analysis of 4 years shows Immuneering's Shares Issued stood at $119.4 million in 2021, then slumped by 99.97% to $42,098 in 2022, then tumbled by 81.39% to $7,835 in 2023, then soared by 44,157.08% to $3.5 million in 2024.
- Its Shares Issued was $3.5 million in Q4 2024, compared to $732,458 in Q1 2024 and $7,835 in Q4 2023.